| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SERA PROGNOSTICS, INC. | Director | Class A Common Stock | 57,740 | $176,107 | $3.05 | 05 Dec 2025 | Direct |
| Acrivon Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 225,000 | 01 Oct 2025 | Direct | ||
| SERA PROGNOSTICS, INC. | Director | Stock Option (right to buy) | 25,000 | 05 Jun 2025 | Direct | ||
| Karyopharm Therapeutics Inc. | Director | Nonstatutory Stock Option (right to buy) | 4,600 | 28 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SERA | SERA PROGNOSTICS, INC. | 05 Dec 2025 | 1 | -$891 | 4 | Director | 05 Dec 2025, 17:25 |
| SERA | SERA PROGNOSTICS, INC. | 05 Nov 2025 | 1 | -$672 | 4 | Director | 06 Nov 2025, 17:05 |
| SERA | SERA PROGNOSTICS, INC. | 06 Oct 2025 | 1 | -$717 | 4 | Director | 06 Oct 2025, 16:15 |
| ACRV | Acrivon Therapeutics, Inc. | 01 Oct 2025 | 1 | $0 | 4 | Chief Medical Officer | 03 Oct 2025, 16:28 |
| SERA | SERA PROGNOSTICS, INC. | 05 Sep 2025 | 1 | -$744 | 4 | Director | 05 Sep 2025, 18:37 |
| SERA | SERA PROGNOSTICS, INC. | 05 Aug 2025 | 1 | -$562 | 4 | Director | 05 Aug 2025, 18:07 |
| SERA | SERA PROGNOSTICS, INC. | 07 Jul 2025 | 1 | -$552 | 4 | Director | 08 Jul 2025, 17:08 |
| SERA | SERA PROGNOSTICS, INC. | 05 Jun 2025 | 3 | -$169 | 4 | Director | 06 Jun 2025, 18:39 |
| KPTI | Karyopharm Therapeutics Inc. | 28 May 2025 | 1 | $0 | 4 | Director | 29 May 2025, 16:09 |
| SERA | SERA PROGNOSTICS, INC. | 08 May 2025 | 1 | -$259 | 4 | Director | 09 May 2025, 19:18 |
| ACRV | Acrivon Therapeutics, Inc. | 09 Apr 2025 | 0 | $0 | 3 | Chief Medical Officer | 21 Apr 2025, 16:22 |
| SERA | SERA PROGNOSTICS, INC. | 07 Apr 2025 | 1 | -$358 | 4 | Director | 08 Apr 2025, 17:21 |
| SERA | SERA PROGNOSTICS, INC. | 06 Mar 2025 | 1 | -$412 | 4 | Director | 07 Mar 2025, 19:30 |
| SERA | SERA PROGNOSTICS, INC. | 12 Feb 2025 | 1 | -$463 | 4 | Director | 14 Feb 2025, 16:13 |
| SERA | SERA PROGNOSTICS, INC. | 27 Jan 2025 | 2 | +$34,170 | 4 | Director | 27 Jan 2025, 18:33 |
| SERA | SERA PROGNOSTICS, INC. | 06 Jan 2025 | 1 | -$769 | 4 | Director | 07 Jan 2025, 16:05 |
| SERA | SERA PROGNOSTICS, INC. | 06 Dec 2024 | 1 | -$662 | 4 | Director | 09 Dec 2024, 16:52 |
| SERA | SERA PROGNOSTICS, INC. | 11 Nov 2024 | 1 | -$695 | 4 | Director | 12 Nov 2024, 17:05 |
| SERA | SERA PROGNOSTICS, INC. | 07 Oct 2024 | 1 | -$686 | 4 | Director | 07 Oct 2024, 18:22 |
| SERA | SERA PROGNOSTICS, INC. | 06 Sep 2024 | 1 | -$687 | 4 | Director | 09 Sep 2024, 16:46 |
| SERA | SERA PROGNOSTICS, INC. | 07 Aug 2024 | 1 | -$749 | 4 | Director | 08 Aug 2024, 16:50 |
| SERA | SERA PROGNOSTICS, INC. | 06 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 16:31 |
| KPTI | Karyopharm Therapeutics Inc. | 29 May 2024 | 1 | $0 | 4 | Director | 30 May 2024, 17:32 |
| SERA | SERA PROGNOSTICS, INC. | 08 Jun 2023 | 1 | $0 | 4 | Director | 07 Jul 2023, 16:21 |
| KPTI | Karyopharm Therapeutics Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 16:08 |
| SERA | SERA PROGNOSTICS, INC. | 03 Jun 2022 | 1 | $0 | 4 | Director | 06 Jun 2022, 16:58 |
| KPTI | Karyopharm Therapeutics Inc. | 19 May 2022 | 1 | $0 | 4 | Director | 20 May 2022, 16:07 |
| SERA | SERA PROGNOSTICS, INC. | 14 Jul 2021 | 0 | $0 | 3 | Director | 14 Jul 2021, 21:49 |
| KPTI | Karyopharm Therapeutics Inc. | 21 May 2021 | 1 | $0 | 4 | Director | 21 May 2021, 17:34 |